Logo image of AQB

AQUABOUNTY TECHNOLOGIES (AQB) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:AQB - US03842K3095 - Common Stock

0.93 USD
+0.03 (+3.33%)
Last: 12/31/2025, 8:00:01 PM
0.92 USD
-0.01 (-1.08%)
After Hours: 12/31/2025, 8:00:01 PM
Fundamental Rating

2

Taking everything into account, AQB scores 2 out of 10 in our fundamental rating. AQB was compared to 530 industry peers in the Biotechnology industry. AQB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. AQB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AQB had negative earnings in the past year.
In the past year AQB has reported a negative cash flow from operations.
In the past 5 years AQB always reported negative net income.
AQB had a negative operating cash flow in each of the past 5 years.
AQB Yearly Net Income VS EBIT VS OCF VS FCFAQB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -365.49%, AQB is doing worse than 92.45% of the companies in the same industry.
AQB has a worse Return On Equity (-721.82%) than 76.98% of its industry peers.
Industry RankSector Rank
ROA -365.49%
ROE -721.82%
ROIC N/A
ROA(3y)-154.24%
ROA(5y)-97.11%
ROE(3y)-323.04%
ROE(5y)-198.77%
ROIC(3y)N/A
ROIC(5y)N/A
AQB Yearly ROA, ROE, ROICAQB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for AQB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AQB Yearly Profit, Operating, Gross MarginsAQB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K

More info and screens

4

2. Health

2.1 Basic Checks

AQB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AQB has been increased compared to 1 year ago.
AQB has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, AQB has a worse debt to assets ratio.
AQB Yearly Shares OutstandingAQB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
AQB Yearly Total Debt VS Total AssetsAQB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -22.11, we must say that AQB is in the distress zone and has some risk of bankruptcy.
AQB has a worse Altman-Z score (-22.11) than 83.58% of its industry peers.
There is no outstanding debt for AQB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -22.11
ROIC/WACCN/A
WACC6.53%
AQB Yearly LT Debt VS Equity VS FCFAQB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

A Current Ratio of 0.12 indicates that AQB may have some problems paying its short term obligations.
The Current ratio of AQB (0.12) is worse than 93.77% of its industry peers.
AQB has a Quick Ratio of 0.12. This is a bad value and indicates that AQB is not financially healthy enough and could expect problems in meeting its short term obligations.
AQB has a worse Quick ratio (0.12) than 93.40% of its industry peers.
Industry RankSector Rank
Current Ratio 0.12
Quick Ratio 0.12
AQB Yearly Current Assets VS Current LiabilitesAQB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

3

3. Growth

3.1 Past

AQB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -19.31%.
The Revenue for AQB has decreased by -100.00% in the past year. This is quite bad
EPS 1Y (TTM)-19.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.23%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

Based on estimates for the next years, AQB will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.23% on average per year.
AQB is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 74.02% yearly.
EPS Next Y86.82%
EPS Next 2Y25.67%
EPS Next 3Y16.68%
EPS Next 5Y12.23%
Revenue Next Year43.65%
Revenue Next 2Y-25.67%
Revenue Next 3Y40.31%
Revenue Next 5Y74.02%

3.3 Evolution

AQB Yearly Revenue VS EstimatesAQB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2M 4M 6M 8M
AQB Yearly EPS VS EstimatesAQB Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -5 -10 -15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

AQB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year AQB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AQB Price Earnings VS Forward Price EarningsAQB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AQB Per share dataAQB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15 -20

4.3 Compensation for Growth

AQB's earnings are expected to grow with 16.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.67%
EPS Next 3Y16.68%

More info and screens

0

5. Dividend

5.1 Amount

AQB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

AQUABOUNTY TECHNOLOGIES

NASDAQ:AQB (12/31/2025, 8:00:01 PM)

After market: 0.92 -0.01 (-1.08%)

0.93

+0.03 (+3.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-03 2025-11-03
Earnings (Next)03-25 2026-03-25/amc
Inst Owners10.97%
Inst Owner Change48.03%
Ins Owners1.38%
Ins Owner Change0%
Market Cap3.61M
Revenue(TTM)N/A
Net Income(TTM)-88.35M
Analysts45
Price TargetN/A
Short Float %0.31%
Short Ratio0.25
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-100%
Min Revenue beat(2)-100%
Max Revenue beat(2)-100%
Revenue beat(4)0
Avg Revenue beat(4)-100%
Min Revenue beat(4)-100%
Max Revenue beat(4)-100%
Revenue beat(8)1
Avg Revenue beat(8)-48.78%
Revenue beat(12)3
Avg Revenue beat(12)-34.44%
Revenue beat(16)4
Avg Revenue beat(16)-29.38%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.29
P/tB 0.29
EV/EBITDA N/A
EPS(TTM)-22.82
EYN/A
EPS(NY)-7.35
Fwd EYN/A
FCF(TTM)-1.75
FCFYN/A
OCF(TTM)-1.69
OCFYN/A
SpS0
BVpS3.15
TBVpS3.15
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -365.49%
ROE -721.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-154.24%
ROA(5y)-97.11%
ROE(3y)-323.04%
ROE(5y)-198.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 700%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.12
Quick Ratio 0.12
Altman-Z -22.11
F-Score2
WACC6.53%
ROIC/WACCN/A
Cap/Depr(3y)2285.55%
Cap/Depr(5y)1493.12%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.23%
EPS Next Y86.82%
EPS Next 2Y25.67%
EPS Next 3Y16.68%
EPS Next 5Y12.23%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next Year43.65%
Revenue Next 2Y-25.67%
Revenue Next 3Y40.31%
Revenue Next 5Y74.02%
EBIT growth 1Y95.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year80.59%
EBIT Next 3Y32.51%
EBIT Next 5Y22.74%
FCF growth 1Y93.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y69.51%
OCF growth 3YN/A
OCF growth 5YN/A

AQUABOUNTY TECHNOLOGIES / AQB FAQ

Can you provide the ChartMill fundamental rating for AQUABOUNTY TECHNOLOGIES?

ChartMill assigns a fundamental rating of 2 / 10 to AQB.


What is the valuation status of AQUABOUNTY TECHNOLOGIES (AQB) stock?

ChartMill assigns a valuation rating of 0 / 10 to AQUABOUNTY TECHNOLOGIES (AQB). This can be considered as Overvalued.


What is the profitability of AQB stock?

AQUABOUNTY TECHNOLOGIES (AQB) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for AQB stock?

The Earnings per Share (EPS) of AQUABOUNTY TECHNOLOGIES (AQB) is expected to grow by 86.82% in the next year.